Vasostrict (vasopressin in 5% Dextrose) Injection, 20 units per 100 mL (0.2 units per mL), 100 mL x 10 Single Dose Vials per carton, Ready to Use, For Intravenous Infusion, Rx Only, Distributed by: Par Pharmaceutical, Chestnut Ridge, NY 10977. NDC: 42023-237-10
Published January 24, 2024 · Recall initiated: January 11, 2024
Summary
FDA records drug Class II recall D-0232-2024, published January 24, 2024 and initiated January 11, 2024. Recalling firm: Par Sterile Products LLC; Status: Ongoing; Reported quantity: 1721 cartons; Lot: Lot # 66702; Exp. 02/2025. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Superpotent Drug: Assay from the 3-month and 6-month stability intervals exceeded the upper specification limit.
What to do
Voluntary: Firm initiated · Letter
Get an email if VASOSTRICT has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- VASOSTRICT
- Manufacturer
- Par Sterile Products LLC
- Distributor
- Nationwide USA
- Lot
- Lot # 66702; Exp. 02/2025
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDAFreskaro refresh & revitalize Magnesium Citrate Saline Laxative Oral Solution Cherry Flavor 10 fl. oz,January 24, 2024
- FDA4.2% Sodium Bicarbonate Injection, USP 5 mEq/10 mL (0.5 mEq/mL), Glass ABBOJECT Unit of Use Syringe, ForJanuary 24, 2024
- FDAFreskaro refresh & revitalize Magnesium Citrate Saline Laxative Oral Solution Grape Flavor 10 fl. oz,January 24, 2024
- FDA8.4 % Sodium Bicarbonate Injection, USP 50 mEq/50 mL (1 mEq/mL), Lifeshield, Glass ABBOJECT Unit of UseJanuary 24, 2024
- FDACVS Health Magnesium Citrate Saline Laxative Oral Solution DYE FREE Grape Flavor 10 fl. oz, Distributed by:January 24, 2024
- FDAAtropine Sulfate Injection, USP 1 mg/10 mL (0.1 mg/mL), Lifeshield, Glass ABBOJECT Unit of Use Syringe, RxJanuary 24, 2024
Questions about this recall
Was Vasostrict (vasopressin in 5% Dextrose) Injection, 20 units per 100 mL (0.2 units per mL), 100 mL x 10 Single Dose Vials per carton, Ready to Use, For Intravenous Infusion, Rx Only, Distributed by: Par Pharmaceutical, Chestnut Ridge, NY 10977. NDC: 42023-237-10 recalled?
Yes. FDA published recall D-0232-2024 on January 24, 2024. Reported hazard: Superpotent Drug: Assay from the 3-month and 6-month stability intervals exceeded the upper specification limit.
What should I do if I have this product?
Voluntary: Firm initiated · Letter
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: VASOSTRICT.